Canine diabetic research

People: Brian Catchpole

At The Royal Veterinary College we have established a national canine diabetes register. This includes a database of clinical information and an archive of residual samples. This diabetic register should allow us to progress our understanding of the causes of this disease.

Correlation of genotype with phenotype: Moving towards individual pharmacogenomic treatment for canine inflammatory bowel disease

People: Atiyeh Peiravan, Karin Allenspach

At the Royal Veterinary College, We are investigating the genetic cause of Inflammatory Bowel Disease (IBD) in German shepherd dogs (GSDs), part of which we will be setting up a new DNA archive of GSD samples. We are looking for blood or saliva samples from GSDs that have been diagnosed with IBD as ‘cases’, and from GSDs without IBD that are over 8 years old as ‘controls’.

Diabetic Remission Clinic

People: Ruth Gostelow, Katarina Hazuchova, Chris Scudder, Stijn Niessen, Yaiza Forcada, David Church

The Diabetic Remission Clinic investigates the optimum management for diabetic cats, and cats in diabetic remission. This includes investigating factors that increase the chance of diabetic remission and prevent cats in remission from relapsing. The clinic is opening a new clinical trial to investigate the benefit of a drug promoting insulin secretion in preventing relapse of diabetes mellitus.

Investigating the Effects of Ketogenic Medium-Chain Triglyceride (MCT) Supplement on Canine Epilepsy

People: Benjamin-Andreas Berk, Rowena Packer, Holger Volk

At the Queen Mother Hospital for Animals we are carrying out a study focusing on the dietary effects of Medium-Chain Triglyceride (MCT) oil given as a daily supplement on seizure frequency, severity, and behavioural co-morbidities of dogs diagnosed with idiopathic epilepsy. This study includes, besides complete blood check-up, non-invasive and interactive behavioural tests on cognition, anxiety, and gait. 

The long-term influence of a medium chain fatty acid diet on canine idiopathic epilepsy - LifeTIME (Long Term remission Mct Epilepsy) study

People: Holger Volk, Elsa Beltran, Joe Fenn, Rowena Packer, Tsz Law

Dietary management for epilepsy is commonly used in humans, and recent studies at RVC have demonstrated that a diet containing medium-chain-triglycerides (MCTs) can reduce seizure frequency, and improve behaviour in some dogs with epilepsy. The purpose of the present trial is to confirm the efficacy of an MCT enriched diet in the management of dogs with idiopathic epilepsy. We will use a parallel design, which means that your dog will either receive a standard high-quality diet or the same diet enriched with MCT.

Top of page